Continuous Renal Replacement Therapy Market to Attain a Value of US $1000 Mn by 2025; Increasing Prevalence of Acute Kidney Injury Drives the Expansion of the Market
Continuous renal replacement therapy (CRRT) is used to treat acute kidney injury of critically ill patients admitted in the intensive care unit. Patients with acute renal failure along with complications such as imperfections or multiple organ failure in their circulatory system or cardiac that include edema and cardiac insufficiency are also treated by the use of CRRT. The other complications for which CRRT is used include postoperative liver failure, fulminant hepatitis, serve acute pancreatitis, and multiple organ failure. In 2016,...
View full press release